Multimodal Ultrasound in Peripheral Neuropathy
Not yet recruiting
- Conditions
- Peripheral Neuropathy
- Registration Number
- NCT06711133
- Lead Sponsor
- Assiut University
- Brief Summary
This study will enforce the role of ultrasound in early diagnosis and screening on peripheral neuropathy in comparison with other modalities.
- Detailed Description
Each case will undergo informed Written consent and will be told the aim of the study including benefits, no harm from this procedure to the participants.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- patients with clinical symptoms of peripheral neuropathy
Exclusion Criteria
- patients with unhealthy tissue texture to put on probe
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Role of multimodal ultrasonography in evaluation of peripheral neuropathy 3 years Enforce the role of ultrasound in screening and early detection of nerve affection in peripheral neuropathy in comparison with the traditional modalities as nerve biopsy and nerve conduction
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does multimodal ultrasonography detect molecular biomarkers in peripheral neuropathy subtypes?
What are the comparative diagnostic accuracies of multimodal ultrasound vs. EMG in early neuropathy detection?
Which nerve structural biomarkers identified by ultrasound predict response to neurotrophic therapies in neuropathy?
What are the potential adverse events associated with multimodal ultrasonography in neuropathy screening?
How does ultrasound-based early diagnosis of peripheral neuropathy influence treatment with anti-inflammatory agents?